![]() |
市場調查報告書
商品編碼
1946057
全球小型動物專科醫療保健市場:預測(至2034年)-依動物種類、專科醫療保健類型、服務類型、設施類型、最終使用者和地區進行分析Small Animal Specialty Care Market Forecasts to 2034 - Global Analysis By Animal Type (Dogs, Cats, Other Small Animals), Specialty Care Type, Service Type, Facility Type, End User and By Geography |
||||||
根據 Stratistics MRC 的研究,預計到 2026 年,全球小動物專科醫療保健市場將達到 1,677 億美元,並在預測期內以 7.5% 的複合年成長率成長,到 2034 年達到 2,991 億美元。
小動物專科醫療是指專注於診斷、治療和長期管理伴侶動物(如犬、貓和其他小型寵物)複雜健康問題的高級獸醫服務。這些服務由專業認證的獸醫專科醫生提供,涵蓋心臟病學、腫瘤學、神經病學、整形外科、皮膚病學和內科等多個領域。這些服務運用專業的診斷工具、先進的影像技術、外科手術和實證治療方法,通常透過轉診中心和專科醫院提供,從而確保全面、高品質的患者照護。
寵物主人數量的增加和寵物擬人化
全球寵物飼養量的成長以及寵物人性化趨勢的日益盛行,是推動小型動物專科獸醫市場發展的主要因素。飼主越來越將寵物視為家庭成員,並願意投資先進的治療方法來改善它們的生命品質並延長其壽命。這種轉變促使飼主要求與人類醫療保健服務相媲美的全面、高品質的護理,從而增加了對腫瘤科、心臟科和皮膚科等專科獸醫服務的需求。這正在推動市場擴張。
專業獸醫護理高成本
小型動物專科獸醫護理的高昂費用仍然是阻礙因素。先進的診斷技術、專業的外科手術以及由認證獸醫進行的治療都會顯著增加整體治療成本。這些費用可能會限制人們獲得獸醫服務的機會,尤其是在價格敏感地區和沒有寵物保險的飼主中。儘管人們的意識正在提高,但成本方面的挑戰仍然阻礙了專科服務的廣泛普及,尤其是在寵物保險普及率較低的新興市場。
獸醫學進展
獸醫學的持續進步為市場帶來了巨大的成長機會。影像學、微創手術、再生醫學和標靶治療領域的創新正在改善複雜動物疾病的治療效果。此外,數位健康工具、遠距醫療和人工智慧輔助診斷的整合正在提高臨床效率和準確性。這些進步正在拓展專科醫療服務的範圍,並推動獸醫專業人員和寵物飼主對這些技術的接受度不斷提高。
監理和合規挑戰
監管和合規方面的挑戰對小型動物專科獸醫市場構成重大威脅。獸醫機構必須遵守有關醫療程序、藥物使用、資料管理和動物福利的嚴格標準,而這些標準可能因地區而異。頻繁的監管更新增加了專科醫院營運的複雜性和合規成本。未能滿足這些要求可能會導致罰款和服務限制,這可能會阻礙市場擴張和跨國服務提供。
新冠疫情對小型動物專科獸醫市場產生了複雜的影響。雖然最初的封鎖措施擾亂了人們前往獸醫診所就診和進行擇期手術,但疫情也促使寵物領養數量增加,並提高了人們對寵物健康的關注度。隨著時間的推移,在治療延期和寵物飼養量增加的推動下,對專科獸醫服務的需求強勁復甦。獸醫診所轉向遠端醫療並加強了安全措施,加速了專科獸醫生態系統的數位轉型。
在預測期內,皮膚科領域預計將佔據最大的市場佔有率。
預計在預測期內,皮膚病學領域將佔據最大的市場佔有率。這主要是由於伴侶動物皮膚相關疾病的高發生率。過敏、感染疾病、寄生蟲感染和慢性皮膚病在犬貓中十分常見,需要頻繁就診。人們對皮膚病的認知不斷提高、診斷能力不斷增強以及先進的局部和全身療法的廣泛應用,進一步鞏固了該領域在專科獸醫學中的主導地位。
預計在預測期內,外科手術服務業將呈現最高的複合年成長率。
在預測期內,外科服務業預計將呈現最高的成長率,這主要得益於對先進微創手術需求的不斷成長。手術器械、麻醉和術後護理技術的進步提高了安全性和治療效果,從而支撐了這一成長。此外,小型動物創傷、整形外科疾病、癌症和先天性異常病例的增加也促進了專業外科手術的普及。
在預測期內,北美預計將保持最大的市場佔有率,這主要得益於其較高的寵物擁有率、完善的獸醫基礎設施以及先進的專業服務普及率。大型動物醫院的存在、眾多認證專家的湧現以及寵物飼主較高的健康意識,都鞏固了其市場主導地位。此外,該地區優惠的寵物保險覆蓋範圍和較高的可支配收入水準也進一步推動了對高階專業獸醫服務的需求。
在預測期內,亞太地區預計將呈現最高的複合年成長率,這主要得益於快速的都市化、寵物飼養量的增加以及可支配收入的成長。人們對動物健康的日益關注、專業獸醫診所的擴張以及先進醫療技術的普及,都在推動市場成長。此外,人們對寵物的文化態度轉變以及對獸醫基礎設施投資的增加,也加速了全部區域小型動物專業獸醫服務的普及。
According to Stratistics MRC, the Global Small Animal Specialty Care Market is accounted for $167.7 billion in 2026 and is expected to reach $299.1 billion by 2034 growing at a CAGR of 7.5% during the forecast period. Small Animal Specialty Care refers to advanced veterinary medical services focused on the diagnosis, treatment, and long-term management of complex health conditions in companion animals such as dogs, cats, and other small pets. It is delivered by board-certified veterinary specialists across disciplines including cardiology, oncology, neurology, orthopedics, dermatology, and internal medicine. These services employ specialized diagnostic tools, advanced imaging, surgical interventions, and evidence-based therapies, typically provided through referral centers or specialty hospitals to support comprehensive, high-quality patient care.
Rising pet ownership and humanization of pets
The growing global pet population, coupled with the increasing humanization of companion animals, is a major driver of the small animal specialty care market. Pet owners increasingly view animals as family members and are willing to invest in advanced medical treatments to enhance quality of life and longevity. This shift has led to higher demand for specialized veterinary services, including oncology, cardiology, and dermatology, as owners seek comprehensive, high-standard care comparable to human healthcare services. Thus, it drives market expansion.
High cost of specialty veterinary care
The high cost associated with small animal specialty care remains a key restraint for market growth. Advanced diagnostics, specialized surgical procedures, and treatment by board-certified veterinarians significantly increase overall treatment expenses. These costs can limit access, particularly in price-sensitive regions and among uninsured pet owners. Despite rising awareness, affordability challenges continue to restrict widespread adoption of specialty services, especially in emerging markets with limited pet insurance penetration.
Advancements in veterinary medicine
Continuous advancements in veterinary medicine present significant growth opportunities for the market. Innovations in diagnostic imaging, minimally invasive surgeries, regenerative medicine, and targeted therapeutics are improving treatment outcomes for complex animal health conditions. Additionally, the integration of digital health tools, teleconsultations, and AI-assisted diagnostics is enhancing clinical efficiency and accuracy. These advancements are expanding the scope of specialty care and encouraging greater adoption among veterinary professionals and pet owners.
Regulatory and compliance challenges
Regulatory and compliance challenges pose a notable threat to the small animal specialty care market. Veterinary practices must adhere to stringent standards related to medical procedures, drug usage, data management, and animal welfare, which can vary significantly across regions. Frequent regulatory updates increase operational complexity and compliance costs for specialty hospitals. Failure to meet these requirements can result in penalties or service limitations, potentially hindering market expansion and cross border service delivery.
The COVID-19 pandemic had a mixed impact on the Small Animal Specialty Care Market. While initial lockdowns disrupted veterinary visits and elective procedures, the pandemic also led to a surge in pet adoption and heightened focus on pet health. Over time, demand for specialty care rebounded strongly, supported by deferred treatments and increased pet ownership. Veterinary practices adopted telemedicine and enhanced safety protocols, accelerating digital transformation within the specialty care ecosystem.
The dermatology segment is expected to be the largest during the forecast period
The dermatology segment is expected to account for the largest market share during the forecast period, due to the high prevalence of skin-related conditions in companion animals. Allergies, infections, parasitic infestations, and chronic dermatological disorders are common among dogs and cats, driving frequent veterinary consultations. Increasing awareness, improved diagnostic capabilities, and the availability of advanced topical and systemic therapies further supports the dominance of this segment in specialty veterinary care.
The surgical services segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the surgical services segment is predicted to witness the highest growth rate, due to rising demand for advanced and minimally invasive procedures. Growth is supported by technological advancements in surgical equipment, anesthesia, and post operative care, which improve safety and outcomes. Increasing cases of trauma, orthopedic disorders, cancer, and congenital abnormalities in small animals are also contributing to higher adoption of specialized surgical interventions.
During the forecast period, the North America region is expected to hold the largest market share, due to high pet ownership rates, well-established veterinary infrastructure, and strong adoption of advanced specialty services. The presence of leading veterinary hospitals, widespread availability of board-certified specialists, and high awareness among pet owners support market dominance. Additionally, favorable pet insurance coverage and higher disposable income levels further drive demand for premium specialty care services in the region.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR, owing to rapid urbanization, increasing pet adoption, and rising disposable incomes. Growing awareness of animal health, expansion of veterinary specialty clinics and improving access to advanced medical technologies are fueling market growth. Additionally, evolving cultural attitudes toward pets and increasing investments in veterinary healthcare infrastructure are accelerating the adoption of small animal specialty care across the region.
Key players in the market
Some of the key players in Small Animal Specialty Care Market include Zoetis Inc., Merck Animal Health (Merck & Co., Inc.), Boehringer Ingelheim International GmbH, Elanco Animal Health Inc., IDEXX Laboratories, Inc., Ceva Sante Animale, Virbac S.A., Vetoquinol S.A., Dechra Pharmaceuticals PLC, Mars Veterinary Health, PetIQ, Inc., Phibro Animal Health Corporation, Neogen Corporation, PetVet Care Centers LLC and MedVet.
In October 2025, Mars and Big Idea Ventures have hand-picked three innovative startups for their 2025 Next Generation Pet Food Program, spotlighting sustainable biotech ingredients and circular feed solutions to transform pet nutrition and reduce environmental impact.
In March 2025, Mars, has extended its partnership with the Washington Spirit, becoming the team's Official Petcare Partner, with its logo featured on jerseys and signage, community ticket donations, pet-friendly game nights, and collaborative fan and pet experiences.
Note: Tables for North America, Europe, APAC, South America, and Rest of the World (RoW) are also represented in the same manner as above.